Bioinformatics Platforms Market is expanding with Dassault Systemes SE acquiring Medidata Solutions to take leverage of Medidata’s cloud-based services to help the development of therapeutic innovations
Developed regions such as North
America, typically the U.S. have shown the most promising signs when it comes
to the bioinformatics platforms market. This is due to high adoption of new and
advanced technology, which is complemented by continuous research and
development activates in the region. Similarly, Asia Pacific is witnessing
increased interest in the field of bioinformatics platforms due to the presence
of skilled personnel.
Bioinformatics Platforms are
collections of software applications designed to facilitate the analysis of
biological information. The applications and their main functions are divided
into three categories, these are Cloning Lines of Action, Gene Regulation, and
Gene Function. They all can be combined into one application for better
functionality. However, the applications vary depending on the needs of the
user and the complexity of the job. Bioinformatics is widely used in research
and development activities for either drug discovery, clinical diagnostics, or
personalized medicine. Such thorough and highly advanced research activities
require collaborative work, in order to leverage the expertise of both private
and public organizations. Recently, in October 2020, The Walther Cancer
Foundation invested around US$ 11 million to expand collaborative
bioinformatics cancer research with Indiana University and Purdue University.
Similarly, in January 2021, Curie-Cancer entered into a bioinformatics
partnership deal with GenoSplice Technology for the application of cancer
genomics. Such partnership and collaboration activities can stimulate growth of
the bioinformatics
platforms market.
Bioinformatics platforms are usually
developed using applications written in C++. The source code is made
human-readable to allow users to quickly analyze the data and manipulate it.
Examples of these applications include the Illumina Genomics Platform, Gene
Array Expression Profiling Software, and Genomics Data Migration Tool. In the
recent past, the demand for nucleic acid and protein sequencing has increased
massively. This is due to the fact that sequencing cost has reduced
substantially, which is complemented by technological advancements. Such
positive factors are also augmenting growth of the bioinformatics platforms
market.
Recently, in June 2019, Dassault
Systemes SE, a French software company, acquired Medidata Solutions, a provider
for SaaS-based clinical development software, for US$ 5.8 billion with the aim
to take leverage of Medidata’s cloud-based services to help the development of
therapeutic innovations and clinical operations performance for pharmaceutical
companies.
Good bioinformatics applications
should be open source. This means the software should have a collaborative
development plan and be collaboratively supported. Currently, there are many
open-source applications available. To see what applications are currently out
there check out the Bioinet website. Despite all these positive factors, the
bioinformatics platforms market is hindered by a lack of well-defined standards
and common data formats for the integration of data. Besides, the low
availability of user-friendly tools at competitive prices can restrain growth
of the bioinformatics platforms market.
Comments
Post a Comment